CEREBRAL HYPOPERFUSION AND COGNITIVE IMPAIRMENTS


如何引用文章

全文:

详细

The article discusses the problem of the correlation of brain function with cerebral blood flow. The causes, pathogenesis and the effects of cerebral hypoperfusion, including the development of cognitive impairments in patients with decreased cerebral blood flow, as well as the possibility of correction of reduced blood flow are discussed.

参考

  1. Бокерия Л.А., Камчатнов П.Р., Ключников И.В. Цереброваскулярные расстройства у больных с коронарным шунтированием // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. № 3. C. 90-95.
  2. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М., 2001 C.. 327.
  3. Камчатнов П.Р., Каралкин А.В., Чугунов А.В. и соавт. Возможности патогенетической терапии больных сахарным диабетом 2-го типа и дисциркуляторной энцефалопатией // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. № 3. C. 18-24.
  4. Танашян М.М., Домашенко М.А. Трентал при ишемических цереброваскулярных заболеваниях (обзор литературы). Атмосфера // Нервные болезни. 2005. № 4. C. 21-25.
  5. Baron J. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001;11(1):2-8.
  6. Bladin C, Chambers B. Clinical features, pathogenesis and computed tomographic characteristics of internal watershed infarction. Stroke 1993;24:1925-32.
  7. Broe M, Kril J, Halliday G. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 2004;127:2214-20.
  8. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994;5:145-47.
  9. Caffarra P, Ghetti C, Letizia C, et al. Differential Patterns of Hypoperfusion in Subtypes of Mild Cognitive Impairment. The Open Neuroimaging Journal 2008;2:20-28.
  10. Charlesworth D, Likosky D, Marrin C, et al. Development and validation of a prediction model for strokes after coronary artery bypass grafting. Ann Thorac Surg 2003;76:436-43.
  11. Dai W, Lopez O, Carmichael O, et al. Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR Imaging Radiology 2009;250(3):856-66.
  12. DeCarli C, Miller B, Swan G, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke 1999;30:529-36.
  13. Desmond D, Moroney J, Sano M, et al. Incidence of Dementia After Ischemic Stroke: Results of a Longitudinal Study. Stroke 2002;33:2254-62.
  14. Farkas E, De Vos R, Steur E, et al. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related? Neurobiol Aging 2000;21(2):235-43.
  15. de Groot J, de Leeuw F, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000;47:145-51.
  16. de la Torre J. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord 2000;14(1):72-81.
  17. Gonzalez M, Selwyn A. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med. 2003;115(8):99-106.
  18. Hadjiev D, Mineva P. Antihypertensive treatment in elderly hypertensives without a history of stroke and the risk of cognitive disorders. Acta Neurol Scand 2008;118(3):139-45.
  19. Hunter J, Chien K. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999;341:1276-83.
  20. Jefferson A, Poppas A, Paul R, et al. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 2007;28:477-83.
  21. Jefferson A, Tate D, Poppas A, et al. Lower Cardiac Output Is Associated with Greater White Matter Hyperintensities in Older Adults with Cardiovascular Disease. J Am Geriatr Soc 2007;55(7):1044-48.
  22. Johnson N, Jahng GH, Weiner M, et al. Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience. Radiology 2005;234:851-59.
  23. Johnston S, O'Meara S, Manolio A, et al. Cognitive Impairment and Decline Are Associated with Carotid Artery Disease in Patients without Clinically Evident Cerebrovascular Disease. Ann Intern Med. 2004;140:237-47.
  24. Lazarus R, Prettyman R, Cherryman G. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders. Int J Geriatr Psychiatry 2005;20:274-79.
  25. Lovenstone S, Gauthier S. Management of dementia. London: Martin Dunitz 2001.
  26. Mathiesen E, Waterloo K, Joakimsen O, et al. Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromso Study. Neurology 2004;62(5):695-701.
  27. Nagamachi S, Nishikawa T, Ono S, et al. Regional cerebral blood flow in diabetic patients: evaluation by N-isopropyl-123I-IMP with SPECT. Nucl Med Commun 1994;15:455-60.
  28. Pantoni L, Garcia J. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann N Y Acad Sci 1997;826:92-102.
  29. Pantoni L. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. J Neurol Sci 2004;226(1-2):67-70.
  30. Pavics L, Grunwald F, Reichmann K, et al. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test and Alzheimer's dementia. Eur J Nucl Med 1999;26:239-45.
  31. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7(8):683-9.
  32. Raetsch C, Jia J, Boigk G, et al. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut 2002;50:241-47.
  33. Rosenberg G, Sullivan N, Esiri M. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 2001;32:1162-68.
  34. Roman G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc) 2000;36(9):641-53.
  35. Sabri O, Hellwig D, Schreckenberger M, et al. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 2000;21:19-29.
  36. Sarti C, Pantoni L, Bartolini L, et al. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J Neurol Sci 2002;203-204:263-266.
  37. Savas S, Delibas N, Savas C, et al. Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits Spinal Cord 2002;40:224-29.
  38. Sha M, Callahan C. The efficacy of pentoxifylline in the treatment of vascular dementia: a systematic review. Alzheimer Dis Assoc Disord 2003;17(1):46-54.
  39. Shaw S, Shah M, Williams S, et al. Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 2009;11(2):113-18.
  40. Shibata M, Ohtani R, Ihara M, et al. White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion. Stroke 2004;35;2598-603.
  41. Shimizu S, Zhang Y, Laxamana J, et al. Concordance and Discordance Between Brain Perfusion and Atrophy in Frontotemporal Dementia. Brain Imaging and Behavior 2010;4:46-54.
  42. Soneira C, Scott T. Severe cardiovascular disease and Alzheimer's disease: senile plaque formation in cortical areas. Clin Anat 1996;9:118-27.
  43. Sulkava R, Erkinjuntti T. Vascular dementia due to cardiac arrhythmias and systemic hypotension. Acta Neurol Scand 1987;76:123-28.
  44. Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer Disease. Stroke 2002;33;1986-92.
  45. Tiehuis A, van den Berg E, et al. Cerebral perfusion in relation to cognitive function and type 2 diabetes. Diabetologia 2008;51:1321-26.
  46. Tosun D, Schuff N, Weiner M. An Integrated Multimodality MR Brain Imaging Study: Gray Matter Tissue Loss Mediates The Association Between Cerebral Hypoperfusion and Alzheimer's Disease. Conf Proc IEEE Eng Med Biol Soc 2009;1:6981-84.
  47. Tsuchiya M, Sako K, Yura S, et al. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res 1992;89:87-92.
  48. Ueno M, Tomimoto H, Akiguchi I, et al. Blood-brain barrier is disrupted in the white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 2002;22:97-104.
  49. van Laar P, van der G, Mali W, et al. Effect of cerebrovascular risk factors on regional cerebral blood flow. Radiology 2008;246:198-204.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2010
##common.cookie##